SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments

INTRODUCTION: The study aims to evaluate the concentration of IgG antibodies against the receptor-binding domain of the SARS-CoV-2 spike1 protein (S1RBD) in BNT162b2- vaccinated relapsing-remitting multiple sclerosis (RRMS) individuals receiving disease-modifying treatments (DMTs). METHODS: Serum fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambrianides, Anastasia, Deeba, Elie, Hadjiagapiou, Maria, Pantzaris, Marios, Krashias, George, Christodoulou, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998932/
https://www.ncbi.nlm.nih.gov/pubmed/36908621
http://dx.doi.org/10.3389/fneur.2023.1092999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998932/
https://www.ncbi.nlm.nih.gov/pubmed/36908621
http://dx.doi.org/10.3389/fneur.2023.1092999

Ejemplares similares